368 related articles for article (PubMed ID: 32844197)
1. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
Sharp ME; Duncan K; Foerde K; Shohamy D
Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
[TBL] [Abstract][Full Text] [Related]
2. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
3. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
4. A trade-off between feedback-based learning and episodic memory for feedback events: evidence from Parkinson's disease.
Foerde K; Braun EK; Shohamy D
Neurodegener Dis; 2013; 11(2):93-101. PubMed ID: 23036965
[TBL] [Abstract][Full Text] [Related]
5. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
6. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
7. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease.
Grogan JP; Tsivos D; Smith L; Knight BE; Bogacz R; Whone A; Coulthard EJ
Elife; 2017 Jul; 6():. PubMed ID: 28691905
[TBL] [Abstract][Full Text] [Related]
9. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
10. Two routes to value-based decisions in Parkinson's disease: differentiating incremental reinforcement learning from episodic memory.
Montaser-Kouhsari L; Nicholas J; Gerraty RT; Shohamy D
bioRxiv; 2024 May; ():. PubMed ID: 38746345
[TBL] [Abstract][Full Text] [Related]
11. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
[TBL] [Abstract][Full Text] [Related]
12. Dopamine selectively remediates 'model-based' reward learning: a computational approach.
Sharp ME; Foerde K; Daw ND; Shohamy D
Brain; 2016 Feb; 139(Pt 2):355-64. PubMed ID: 26685155
[TBL] [Abstract][Full Text] [Related]
13. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
[TBL] [Abstract][Full Text] [Related]
14. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
Simioni AC; Dagher A; Fellows LK
Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
[TBL] [Abstract][Full Text] [Related]
15. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease.
van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA
Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079
[TBL] [Abstract][Full Text] [Related]
16. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
[TBL] [Abstract][Full Text] [Related]
17. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?
Smittenaar P; Chase HW; Aarts E; Nusselein B; Bloem BR; Cools R
Eur J Neurosci; 2012 Apr; 35(7):1144-51. PubMed ID: 22487043
[TBL] [Abstract][Full Text] [Related]
18. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
Moustafa AA; Sherman SJ; Frank MJ
Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
[TBL] [Abstract][Full Text] [Related]
19. Mind matters: placebo enhances reward learning in Parkinson's disease.
Schmidt L; Braun EK; Wager TD; Shohamy D
Nat Neurosci; 2014 Dec; 17(12):1793-7. PubMed ID: 25326691
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
